The groundbreaking STEP-HFpEF study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named one of the top advances by the American Heart Association.
Dr. Mikhail Kosiborod reviewed research at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease on the cardiovascular benefits of Ozempic/Wegovy for adults with obesity.
One Saint Luke’s East patient took time on Christmas Eve to show appreciation for nurses and other health care workers who are spending the holidays at the hospital caring for others.
What do I do if I’m exposed? How can I stay safe while traveling? What’s the difference between COVID and the flu? Dr. Sarah Boyd, infectious disease physician at Saint Luke's Health System, answers.